National Access Director

Your mission We are looking for creative, highly motivated individuals to help prepare for the successful launch of tab elecleucel ( T ab-cel) , an investigational cell therapy for the treatment of Epstein Barr positive post-transplant lymphoproliferative disease.    The National Access Director will play a critical role in preparing for launch and facilitating urgent access to Tab-cel once approved. In the pre - approval phase, they will work closely with Pierre Fabre’s Cell Therapy Account Directors and Field Medical Directors to support site operational onboarding and readiness leading up to and after the anticipated approval of the Tab-Cel . They will be responsible for pre- and post-approval information exchange s with payers to ensure p ayers have the appropriate data and information required to enable coverage decisions and provide a pathway to coverage for patients who may be prescribed the T ab-cel p ost approval . Critically, they will ensure that financial stakeholders at treating facilities and payers have timely access to information needed to navigate the preparation for the relevant prior authorization process and potential single case agreements .    This is an exciting opportunity to be part of an organization that is preparing to launch a new class of advanced therapeutics while making a meaningful impact on the lives of patients with a life-threatening disease . Pierre Fabre Pharmaceuticals offers unique development opportunities, and we are looking for candidates that have a growth mindset and thrive in a start-up environment that will be scaling up the Pierre Fabre presence in the US pharmaceuticals market. We value individuals who exhibit behaviors such as team collaboration, humility , innovative thinking, and patien t centric approach to the business .    ESSENTIAL FUNCTIONS:   Operate in compliance with all laws, regulations and policies that govern the conduct of Pierre Fabre activities   Facilitate urgent access to Tab-cel post approval by educating payer customer segment and treatment center financial stakeholders of value proposition of product   Contributes to the US Value and Access Team by monitoring trends, policy changes, and implications and taking ownership of this expertise     Seek out opportunities for synergy and partnership to achieve both Pierre Fabre and customer goals through active and transparent planning and customer engagement with cross functional Team.   Tab-Cel Support   Enable payer coverage assessment for Tab-Cel through pre-approval information exchange and post-approval with national and regional payers in the C ommercial, Medicare, and VA sectors   Support overall a ccess s trategy with engagement of Federal Payers and Medicare FFS   Contribute to market access strategic imperatives    Educate payers on the urgent unmet need and provide resources to ensure a pathway to coverage in the pre and post approval regulatory setting   Identify appropriate payer stakeholders for the therapy and partner with payer colleagues to establish path for expedited review of cases   Provide approved product education and health economic information to key customers in payer and provider segment to communicate the value proposition of the product.    Ensure financial and reimbursement confidence and communicate payer coverage with provider s post approval   Partner with treatment sites and key stakeholders to educate on reimbursement process , coverage and coding details relevant for the Therapy post approval , ensuring stakeholder comfort and confidence in their reimbursement process   Liaise with external specialty distributor counterpart (s) to meet objectives while providing a best-in-class experience for sites of care   Proactively communicate payer coverage criteria to internal field teams and external site of care stakeholders   Prepare potential treatment centers to be reimbursement ready before and after anticipated approval   E nsure that providers and payers have timely access to information needed to navigate prior authorizations and the negotiation of single-case agreements ( e.g. c oding , relevant policy, setting of care considerations)   The National Access Director will be the primary field team member responsible for educati on regarding patient assistance programs at sites of care   The National Access Director is the f ield expert in market access related issues related to Trade Policy   N ational Access Director is responsible for partnering with payer relations teams at sites of care to resolve any issues regarding coverage and reimbursem ent   REQUIRED EDUCATION AND EXPERIENCE     Bachelor’s degree required , healthcare degrees or credentials desirable   Strong, pre-existing working experience with national and regional payers that manage medical and pharmacy benefit policy   Deep knowledge of and experience with inpatient and outpatient reimbursement methodology and dynamics and impacts to hospital access economics   10+ years of biotech/pharma required with at least five years of direct experience in coverage and reimbursement dynamics of complex advanced therapies ( E . g . cell therapy, gene therapy, radio ligand)    Strongly Preferred   Experience with cell and gene therapy networks and Medical Director teams at payers that manage Cell Therapy products   Strong presentation skills and executive presence   Exceptional business acumen and hospital administrative expertise     Cell , Gene, Stem Cell Transplant service line experience and established relationships with financial KOL s at institutions   Ability to work in fast-paced and dynamic environment while maintaining cross functional internal relationships and contribute to site of care account planning   Experience with pharmacy/ therapeutics committee and high impact drug review processes at institutions   LOCATION :   US, remote , domestic travel up to 30%   Comp